Browsing Tag
Psychedelic Therapy
3 posts
Can short-acting psychedelics solve the scalability problem in depression treatment?
Short-acting psychedelics like bretisilocin could reshape mental health treatment. Can they overcome the clinical bottlenecks faced by psilocybin and ketamine?
AbbVie’s $1.2bn bet on Gilgamesh’s bretisilocin signals a bold push into next-generation antidepressants
AbbVie to acquire Gilgamesh’s bretisilocin for up to $1.2B to expand its psychiatry pipeline. Find out how this short-acting psychedelic could reshape MDD care.
Is the cure for PTSD waiting in the wings? FDA says not yet!
In a significant regulatory decision, the U.S. Food and Drug Administration (FDA) has decided not to approve the…